Evolving Treatment Landscape in COPD

Author(s):

Fernando J. Martinez, MD, MS,Nicola Hanania, MD, MS

Igor Barjaktarevic, MD, PhD, discusses the evolving treatment landscape in COPD, highlighting current treatment approaches and novel therapies on the horizon.

EP: 1.Why is COPD Important?

EP: 2.COPD Traits Associated with Phenotypes

EP: 3.Insights Gleaned from Asthma Research for COPD

EP: 4.Biomarkers in COPD

EP: 5.Unmet Needs in the COPD Treatment Landscape

EP: 6.The Role of Eosinophils in Diagnosing COPD

EP: 7.GOLD Treatment Guidelines and Evolving Therapeutic Approaches

Now Viewing

EP: 8.Evolving Treatment Landscape in COPD

EP: 9.Emerging Treatment Approaches in COPD

EP: 10.Future Treatment Landscape for COPD

EP: 11.The Benefits of Earlier Diagnosis and Treatment of COPD

EP: 12.The Relationship Between Comorbidities in COPD

EP: 13.The Role of Primary Care Providers in Managing Patients with COPD

EP: 14.Key Takeaways on the Evolving COPD Treatment Landscape

What are the shortcomings of the current treatment approaches and what are novel therapies on the horizon?
Some patients continue to have exacerbation despite triple therapy.
Current therapies do not address type 2 inflammation.